KEFUROX IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Kefurox In Plastic Container patents expire, and what generic alternatives are available?
Kefurox In Plastic Container is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in KEFUROX IN PLASTIC CONTAINER is cefuroxime sodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kefurox In Plastic Container
A generic version of KEFUROX IN PLASTIC CONTAINER was approved as cefuroxime sodium by ACS DOBFAR SPA on May 30th, 1997.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KEFUROX IN PLASTIC CONTAINER?
- What are the global sales for KEFUROX IN PLASTIC CONTAINER?
- What is Average Wholesale Price for KEFUROX IN PLASTIC CONTAINER?
Summary for KEFUROX IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Patent Applications: | 561 |
| DailyMed Link: | KEFUROX IN PLASTIC CONTAINER at DailyMed |
US Patents and Regulatory Information for KEFUROX IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | KEFUROX IN PLASTIC CONTAINER | cefuroxime sodium | INJECTABLE;INJECTION | 062590-002 | Jan 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | KEFUROX IN PLASTIC CONTAINER | cefuroxime sodium | INJECTABLE;INTRAVENOUS | 062590-001 | Jan 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

